RDSMY News 17.0200 Royal D S M Nv ADR (RDSMY)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Royal D S M Nv ADR (RDSMY) 17.0200 $RDSMY

Cimarex Reports Fourth-Quarter and Full-Year 2013 Results (unaudited)
PR Newswire - Wed Feb 19, 7:00AM CST
Cimarex Energy Co. (NYSE: XEC) today reported adjusted fourth-quarter 2013 net income of $117.6 million, or $1.35 per diluted share, compared to fourth-quarter 2012 adjusted net income of $102.8 million, or $1.19 per diluted share(1). For the year, adjusted net income totaled $469.3 million, or $5.38 per diluted share, as compared to 2012 adjusted net income of $366.8 million, or $4.22 per diluted share. See attached table to the financial statements for a full reconciliation of adjusted net income.

OTC Markets Group Reports 2013 Trading Statistics and Highlights
PR Newswire - Wed Jan 29, 9:17AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced its trading statistics and highlights for 2013 as well as its plans for 2014.

DSM Begins Trading on OTCQX®
PR Newswire - Tue Aug 06, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that DSM (OTCQX: RDSMY; NYSE Euronext: DSM), a global science-based company active in health, nutrition and materials, has chosen to have its American Depositary Receipts (ADRs) traded on OTCQX®, the best marketplace with qualified companies.

DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
PR Newswire - Mon Apr 22, 1:00AM CDT
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA

DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
PR Newswire - Mon Apr 22, 1:00AM CDT
The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics, the biopharmaceutical manufacturing business of DSM Pharmaceutical Products, stated, "We are thrilled to announce the June opening of our new cGMP facility in Brisbane. This operation combines DSM's twenty five years of experience and high quality track record in mammalian cell culture manufacturing with a state-of-the-art commercial and development facility. Our partnership with the Government of Queensland and the Commonwealth of Australia has led to this important addition to the Australian biotechnology industry and will be a key contributor to the entire Asia-Pacific region."

Presentations From Deutsche Bank's Depositary Receipts Virtual Investor Conference Now Available for On-demand Viewing
PR Newswire - Thu Mar 28, 7:30AM CDT
Deutsche Bank Depositary Receipts today announced that the archive presentations from their March 19 virtual investor conference are now available for 24/7 viewing. Nine publicly-listed global companies, presented and answered questions live.

International Companies to Host Live Webcasts at Deutsche Bank's March 19 Depositary Receipts Virtual Investor Conference
CNW Group - Wed Mar 13, 4:33PM CDT
Deutsche Bank Depositary Receipts today announced the line-up of its March 19 virtual investor conference, featuring live presentations from nine international companies. Company representatives will respond to questions in real-time during formal presentations and will also interact with investors in virtual trade booths. The conference is primarily targeted to the individual retail investor but is also open to institutional investors and analysts.

DSM signs Master Supply Agreement with Eisai Inc.
PR Newswire - Tue Mar 05, 1:00AM CST
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE/Euronext: DSM KON), today announced the signing of a 3 year master supply agreement with Eisai Inc., based in Woodcliff Lake, NJ, USA, for the production of sterile products. The agreement covers the production of eribulin mesylate as well as other developmental drugs. Alexander Wessels, President and CEO of DSM Pharmaceutical Products, stated, "We are delighted to be working with Eisai under a long-term agreement to serve markets globally for important human health treatments, bringing our expertise and reliability in sterile injectables and worldwide regulatory record to ensure market supply."

DSM announces license agreement with Amgen for use of DSM's XD® Cell Culture Patents
PR Newswire - Tue Jan 15, 1:00AM CST
Karen King, President of DSM Biologics, commented "We are pleased to enter into this license agreement with Amgen, a global leader in biopharmaceutical drug development and manufacturing. We believe our proprietary XD® technology will play an important role in the next generation of biopharmaceutical manufacturing." XD® technology is a highly intensified cell culture process with typical titer achievement of 8-to-10 times higher compared to current standard biomanufacturing processes. For some products, titer improvements of up to 15 times have been achieved. It is widely applicable for multiple biological products including proteins, fusion proteins and antibodies, and has been successfully employed across the full spectrum of mammalian cell systems.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NaLA Pushes for Stronger Lifeline Fraud Measures

Updated Category News Views 79

Here's the thing about the Lifeline program: it's meant to be a lifeline, not a loophole for the crafty and unscrupulous. The National Lifeline Association (NaLA) is slamming the table, demanding that the Senate Commerce Committee put some real muscle into preventing fraud. Why the Urgency on Lifeline Fraud? NaLA’s got its sights on a more robust defensive line against...

Continue Reading
League's AI Launch: A New Era in Healthcare

Updated Category News Views 76

AI: Healthcare's Bold New Move Ah, here we go. Another tech jump in healthcare. This time it's the folks over at League, stirring the pot with some new AI gimmicks. They've slapped together what they call an 'AI Front Door' and an 'AI Care Companion'—part of their Forge by League platform. Now, if there's one thing we know, it's that the healthcare sector loves a good...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 24

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 73

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
S&P Global's Bold $2 Billion Debt Offering Details

Updated Category News Views 80

Drilling Down into S&P Global's Debt Move S&P Global's throwing its hat in the ring with a colossal $2 billion debt offering. Now, they aren't just setting it on the table — they're notably carving it up into three chunks. You’ve got $750 million at 5.600% that comes due in 2031, $600 million at 5.800% for 2034, and $650 million at a 6.000% rate maturing in 2036....

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 88

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
GALC Launches Tender Offer on 2027 Notes Amid Debt Play

Updated Category News Views 70

Aviation Leasing Giant's Strategic Financial Move Well folks, we're staring down the barrel of a financial maneuver by Global Aircraft Leasing Co., Ltd. (GALC) that’s not just another day at the office. They've kicked off a cash tender offer for their 8.750% Senior Secured Notes due 2027, aiming to sweep up any and all outstanding ones. That's $932 million in principle...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 158

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Québecor Makes Its Move: Eye on TELUS Amid Telecom Shakeup

Updated Category News Views 110

The Offer That Shocked the Telecom Markets Just when you think you’ve figured out the lay of the land, someone throws a curveball. Québecor’s decision to take a run at TELUS is shaking up Canada’s telecom scene big time. This isn’t just another M&A whisper; it’s a roaring freight train of a proposal valued at a whopping $31 billion. And TELUS, not just sitting...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 120

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading

Top 5 Most Recently Viewed Articles

BriteCap Financial Achieves Major Funding Milestone

Updated Category News Views 124

BriteCap Financial Achieves Major Funding Milestone BriteCap Financial, a leading small business funding platform, has proudly announced that it has surpassed $1 billion in total originations since its inception. This impressive milestone was achieved in late 2025, highlighting a year of remarkable growth and success for the company. Record Growth in 2025 The achievement...

Continue Reading
Aker Horizons ASA's Upcoming Virtual Annual Meeting Details

Updated Category News Views 261

Aker Horizons ASA Announces Details of Virtual Annual Meeting Aker Horizons ASA, a key player in green energy solutions, has scheduled its annual general meeting to take place online. This digital event will allow shareholders to engage and participate from any location, enhancing accessibility for all stakeholders. Details on the Virtual Meeting The annual general...

Continue Reading
Integrated Analytical Solutions Opens New Cannabis Lab Facility

Updated Category News Views 165

Integrated Analytical Solutions Launches a New Cannabis Testing Facility Integrated Analytical Solutions (IAS), renowned for its analytical testing services, is making strides in the cannabis industry with the grand opening of its state-of-the-art cannabis testing laboratory. This facility is a significant addition to services aimed at promoting safety, quality, and...

Continue Reading
Trip.com Group Files 2024 Annual Report with SEC Insights

Updated Category News Views 1309

Trip.com Group Limited Files Annual Report on Form 20-F Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) has announced the submission of its annual report on Form 20-F. This report includes the company's audited financial statements covering the three years leading up to December 31, 2024, presented to the Securities and Exchange Commission. The filing was made recently...

Continue Reading
Revolutionizing Pediatric Healthcare: Office Practicum's Portal

Updated Category News Views 254

Transforming Pediatric Healthcare with an Innovative Portal Office Practicum is leading the charge in pediatric care by introducing a state-of-the-art Patient Portal, created in partnership with BridgeInteract. This comprehensive tool has been tailored specifically for pediatric practices, presenting a modern and user-friendly platform that serves both families and...

Continue Reading